{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:56:00Z","timestamp":1791982560438,"version":"4.4.0"},"reference-count":50,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82272625"],"award-info":[{"award-number":["No. 82272625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["No. 2026ZD0557403"],"award-info":[{"award-number":["No. 2026ZD0557403"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["No. 22Y31920405"],"award-info":[{"award-number":["No. 22Y31920405"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["No. 2020CXJQ02"],"award-info":[{"award-number":["No. 2020CXJQ02"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/jitc-2026-015873","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:40:16Z","timestamp":1791981616000},"page":"e015873","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy"],"prefix":"10.1136","volume":"14","author":[{"given":"Yunbo","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sencong","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Department of Oncology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Yu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6547-3832","authenticated-orcid":false,"given":"Zhihuang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-0794","authenticated-orcid":false,"given":"Shenglin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Fudan University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-2219","authenticated-orcid":false,"given":"Jialei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101405401362000_14.10.e015873.1","doi-asserted-by":"crossref","unstructured":"Siegel RL , Kratzer TB , Wagle NS , et al . Cancer statistics, 2026. CA A Cancer J Clinicians 2026;76. doi:10.3322\/caac.70043","DOI":"10.3322\/caac.70043"},{"key":"2026101405401362000_14.10.e015873.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013"},{"key":"2026101405401362000_14.10.e015873.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"2026101405401362000_14.10.e015873.4","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e10","article-title":"Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives","volume":"20","author":"Lim","year":"2020","journal-title":"Immune Netw"},{"key":"2026101405401362000_14.10.e015873.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.009"},{"key":"2026101405401362000_14.10.e015873.6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0025"},{"key":"2026101405401362000_14.10.e015873.7","doi-asserted-by":"publisher","DOI":"10.1200\/Jco.21.01497"},{"key":"2026101405401362000_14.10.e015873.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.013"},{"key":"2026101405401362000_14.10.e015873.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"2026101405401362000_14.10.e015873.10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.18.01042","article-title":"First-Line Nivolumab Plus Ipilimumab in Advanced Non\u2013Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers","volume":"37","author":"Ready","year":"2019","journal-title":"JCO"},{"key":"2026101405401362000_14.10.e015873.11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179659","article-title":"Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors","volume":"25","author":"Pavelescu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026101405401362000_14.10.e015873.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.05.019"},{"key":"2026101405401362000_14.10.e015873.13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41392-024-02060-3","article-title":"Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)","volume":"9","author":"Ai","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026101405401362000_14.10.e015873.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.08.004"},{"key":"2026101405401362000_14.10.e015873.15","first-page":"3705","article-title":"Small extracellular vesicles in cancer","volume":"6","author":"Abhange","year":"2021","journal-title":"Bioact Mater"},{"key":"2026101405401362000_14.10.e015873.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1019055108"},{"key":"2026101405401362000_14.10.e015873.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.10.014"},{"key":"2026101405401362000_14.10.e015873.18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14737159.2019.1633307","article-title":"The potential of circulating cell free RNA as a biomarker in cancer","volume":"19","author":"Cheung","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"2026101405401362000_14.10.e015873.19","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1111\/cas.15804","article-title":"Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer","volume":"114","author":"Liao","year":"2023","journal-title":"Cancer Sci"},{"key":"2026101405401362000_14.10.e015873.20","doi-asserted-by":"crossref","first-page":"1421604","DOI":"10.3389\/fimmu.2024.1421604","article-title":"Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"2026101405401362000_14.10.e015873.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01990"},{"key":"2026101405401362000_14.10.e015873.22","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J Clinicians"},{"key":"2026101405401362000_14.10.e015873.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2026101405401362000_14.10.e015873.24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-023-01404-w","article-title":"Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma","volume":"16","author":"Han","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2026101405401362000_14.10.e015873.25","doi-asserted-by":"publisher","DOI":"10.1016\/J.CSBJ.2020.10.002"},{"key":"2026101405401362000_14.10.e015873.26","doi-asserted-by":"publisher","DOI":"10.1038\/S41580-022-00531-5"},{"key":"2026101405401362000_14.10.e015873.27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cac2.70016","article-title":"Blocking ITGA5 potentiates the efficacy of anti\u2010PD\u20101 therapy on glioblastoma by remodeling tumor\u2010associated macrophages","volume":"45","author":"Zhao","year":"2025","journal-title":"Cancer Commun"},{"key":"2026101405401362000_14.10.e015873.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.007"},{"key":"2026101405401362000_14.10.e015873.29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41419-024-07264-7","article-title":"KDELR1 regulates chondrosarcoma drug resistance and malignant behavior through Intergrin-Hippo-YAP1 axis","volume":"15","author":"Yin","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026101405401362000_14.10.e015873.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05806-0"},{"key":"2026101405401362000_14.10.e015873.31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-365635"},{"key":"2026101405401362000_14.10.e015873.32","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-293","article-title":"Differences in integrin expression and signaling within human breast cancer cells","volume":"11","author":"Taherian","year":"2011","journal-title":"BMC Cancer"},{"key":"2026101405401362000_14.10.e015873.33","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws351"},{"key":"2026101405401362000_14.10.e015873.34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602278"},{"key":"2026101405401362000_14.10.e015873.35","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2009"},{"key":"2026101405401362000_14.10.e015873.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.10.016"},{"key":"2026101405401362000_14.10.e015873.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0004-1"},{"key":"2026101405401362000_14.10.e015873.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35727","article-title":"Exosomal CTHRC1 from cancer-associated fibroblasts facilitates endometrial cancer progression via ITGB3\/FAK signaling pathway","volume":"10","author":"Bian","year":"2024","journal-title":"Heliyon"},{"key":"2026101405401362000_14.10.e015873.39","doi-asserted-by":"publisher","DOI":"10.1080\/08916930902831969"},{"key":"2026101405401362000_14.10.e015873.40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317570"},{"key":"2026101405401362000_14.10.e015873.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01802-3"},{"key":"2026101405401362000_14.10.e015873.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99317"},{"key":"2026101405401362000_14.10.e015873.43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718217115"},{"key":"2026101405401362000_14.10.e015873.44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13046-024-03046-3","article-title":"CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy","volume":"43","author":"Qu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026101405401362000_14.10.e015873.45","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.28"},{"key":"2026101405401362000_14.10.e015873.46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood.2024025680","article-title":"The contribution of the monocyte-macrophage lineage to immunotherapy outcomes","volume":"145","author":"Adams","year":"2025","journal-title":"Blood"},{"key":"2026101405401362000_14.10.e015873.47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218127","article-title":"MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer","volume":"21","author":"Schulze","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026101405401362000_14.10.e015873.48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1186\/s12967-024-05763-x","article-title":"Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophages","volume":"22","author":"Fu","year":"2024","journal-title":"J Transl Med"},{"key":"2026101405401362000_14.10.e015873.49","doi-asserted-by":"crossref","first-page":"113713","DOI":"10.1016\/j.intimp.2024.113713","article-title":"The impact of POSTN on tumor cell behavior and the tumor microenvironment in lung adenocarcinoma","volume":"145","author":"Sun","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"2026101405401362000_14.10.e015873.50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65167"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:40:21Z","timestamp":1791981621000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,14]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jitc-2026-015873"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015873","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}